Opportunity
DIBBS #SPE2DP-26-T-4755
DLA Solicitation for Moxifloxacin Hydrochloride Tablets (400 mg, 30-count bottles)
Posted
August 26, 2026
Respond By
August 31, 2026
Identifier
SPE2DP-26-T-4755
NAICS
424210
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharm FSA is seeking to procure Moxifloxacin Hydrochloride Tablets for delivery to a naval vessel. - Government Buyer: - Defense Logistics Agency (DLA) - Sub-agency: DLA Troop Support Medical Supply Chain Pharm FSA - OEMs and Vendors: - TEVA PHARMACEUTICALS USA, INC. - RISING PHARMA HOLDINGS, INC. - Products Requested: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle - NSN: 6505-01-503-4772 - Part numbers: NDC00093-7387-56 (TEVA), NDC57237-0156-30 (RISING PHARMA) - Quantity: 12 bottles - Notable Requirements: - Product must comply with FDA regulations - Packaging and labeling must meet Medical Marking Standard No. 1A - Delivery is FOB destination to USS John Basilone Jr DDG 122 - Compliance with Buy American Act and hazardous material labeling - Delivery required within 5 days after award
Description
MOXIFLOXACIN HYDROCHLO (QTY: 12, NSN: 6505-01-503-4772, Purchase Request: 7018024527) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.